Ryan Alexander Flynn
About Ryan Alexander Flynn
Ryan Alexander Flynn Education
Ryan Alexander Flynn holds dual degrees from Stanford University School of Medicine, encompassing both Medicine (M.D.) and Cancer Biology (Ph.D.). Prior to these advanced studies, he earned an undergraduate degree in Biology from the Massachusetts Institute of Technology (MIT). His educational background provides a rigorous foundation in medical sciences and cancer biology.
Ryan Alexander Flynn Professional Titles
Ryan Alexander Flynn holds multiple titles in the research and academic fields. He serves as the Principal Investigator of the Stem Cell Program within the Hematology/Oncology Division at Boston Children's Hospital. Additionally, he is an Assistant Professor in the Stem Cell and Regenerative Biology Department at Harvard University. He also contributes as a Board Member in various capacities.
Ryan Alexander Flynn Research Expertise
Ryan Alexander Flynn has specific research expertise in RNA biology, stem cell biology, and cancer research. His research contributions are substantial, with an extensive publication record in prestigious scientific journals, including Nature, Cell, and Molecular Cell. His work focuses on understanding the molecular mechanisms in these specialized fields.
Ryan Alexander Flynn Investment Activities
Since 2014, Ryan Alexander Flynn has been an active investor in deep tech and climate tech companies. His investment portfolio includes companies such as Twelve, Windlift, Scindo, and Emerging Fuels Technology. His involvement typically extends beyond mere financial backing to include strategic guidance based on his scientific expertise.
Ryan Alexander Flynn Roles at Boston Children's Hospital and Harvard University
At Boston Children's Hospital, Ryan Alexander Flynn holds the position of Principal Investigator of the Stem Cell Program within the Hematology/Oncology Division. Concurrently, he serves as an Assistant Professor in the Stem Cell and Regenerative Biology Department at Harvard University. These roles highlight his leadership and expertise in both clinical and academic settings.